medline.ch Urologie-Nephrologie Tumoren BPH

	In vivo assessment of bladder cancer with diffuse reflectance and fluorescence spectroscopy: A comparative study. Lasers Surg Med Zlobina NV, Budylin GS, Tseregorodtseva PS, Andreeva VA, Sorokin NI, Kamalov DM, Strigunov AA, Armaganov AG, Kamalov AA, Shirshin EA. PMID: 38650443 [PubMed - as supplied by publisher]
	Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial. JAMA Netw Open Björnebo L, Discacciati A, Falagario U, Vigneswaran HT, Jäderling F, Grönberg H, Eklund M, Nordström T, Lantz A. PMID: 38648061 [PubMed - in process]
	Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study. World J Urol Diamand R, Roche JB, Lacetera V, Simone G, Windisch O, Benamran D, Fourcade A, Fournier G, Fiard G, Ploussard G, Roumeguère T, Peltier A, Albisinni S. PMID: 38647728 [PubMed - in process]
	Precise prostate cancer diagnosis using fluorescent nanoprobes for detecting PSA and PSMA in serum. Chem Commun (Camb) Ouyang M, Jia M, Chang Z, Wang Y, Wang K, Gao X, Tang B. PMID: 38647078 [PubMed - as supplied by publisher]
	Pharmacotherapy considerations for patients who develop acute kidney injury during cancer therapy. Expert Opin Pharmacother Parodi E, Rossi M, Bottiglieri A, Ladetto M, Merlotti G, Cantaluppi V, Quaglia M. PMID: 38646905 [PubMed - as supplied by publisher]
	Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland. Aust J Rural Health Thet Z, Lam AK, Ng SK, Aung SY, Han T, Ranganathan D, Newsham S, Borg J, Pepito C, Khoo TK. PMID: 38646861 [PubMed - indexed for MEDLINE]
	Toward a new personalized psycho-social approach for the support of prostate cancer and their caregivers dyads: a pilot study. Front Med (Lausanne) Cincidda C, Pizzoli SFM, Oliveri S, Guiddi P, Pravettoni G. PMID: 38646557 [PubMed]
	Association between monocyte-to-lymphocyte ratio and prostate cancer in the U.S. population: a population-based study. Front Cell Dev Biol Wang L, Li X, Liu M, Zhou H, Shao J. PMID: 38645410 [PubMed]
	Translation and validation of a lifestyle questionnaire related to prostate cancer. Prostate Karegar-Niavol R, Ghaffari F, Saravi A, Fotokian Z, Kheirkhah F. PMID: 38644626 [PubMed - as supplied by publisher]
	Salvage prostate intensity modulated radiation therapy after cryotherapy failure. Sci Rep Perennec T, Rogé M, Hetet JF, Colls P, Guimas V, Rio E, Vaugier L, Supiot S. PMID: 38644367 [PubMed - indexed for MEDLINE]
	Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic Review and a Network Meta-analysis. Eur Urol Oncol Cerrato C, Crocerossa F, Marchioni M, Giannarini G, Gupta S, Albiges L, Brouwer O, Albersen M, Fankhauser C, Grimm MO, Gandaglia G, Roupret M, Mir MC, ESOU Board. PMID: 38644155 [PubMed - as supplied by publisher]
	Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study. Eur Urol Saad F, Hussain MHA, Tombal B, Fizazi K, Sternberg CN, Crawford ED, Nordquist LT, Bögemann M, Tutrone R, Shore ND, Belkoff L, Fralich T, Jhaveri J, Srinivasan S, Li R, Verholen F, Kuss I, Smith MR. PMID: 38644146 [PubMed - as supplied by publisher]
	Re: Renu S. Eapen, James P. Buteau, Price Jackson, et al. Administering [(177)Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.08.026. Eur Urol Hindié E, Champion C, Morgat C. PMID: 38644143 [PubMed - as supplied by publisher]
	Re: Matthias Boschheidgen, Peter Albers, Heinz-Peter Schlemmer, et al. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial. Eur Urol 2024;85:105-11. Eur Urol Cardona Ortegón JD, Campaña Perilla LA, Olarte Bermúdez LM. PMID: 38644137 [PubMed - as supplied by publisher]
	Efficacy and safety of metronomic cyclophosphamide combined with abiraterone and dexamethasone in heavily pretreated metastatic castration resistant prostate cancerï¼šAâ€‚retrospective,â€‚real-world study. Asian J Surg Zhang L, Zhou L, Shi Y, An X. PMID: 38644125 [PubMed - as supplied by publisher]
	Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management: Preclinical and Clinical Developments of the Past 5 Years. PET Clin Dalm S, Duan H, Iagaru A. PMID: 38644111 [PubMed - as supplied by publisher]
	Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer. Urol Oncol Cei F, Larcher A, Rosiello G, Basile G, Musso G, Re C, Fallara G, Belladelli F, Brembilla G, Guazzarotti G, De Cobelli F, Marandino L, Necchi A, Briganti A, Salonia A, Bertini R, Montorsi F, Capitanio U. PMID: 38644109 [PubMed - as supplied by publisher]
	Cancer on motors: How kinesins drive prostate cancer progression? Biochem Pharmacol Wang JM, Zhang FH, Liu ZX, Tang YJ, Li JF, Xie LP. PMID: 38643904 [PubMed - as supplied by publisher]
	Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate Cancer. Clin Genitourin Cancer Tashiro K, Kimura S, Tsuzuki S, Urabe F, Fukuokaya W, Mori K, Aikawa K, Murakami M, Sasaki H, Miki K, Miki J, Shimomura T, Yamada H, Hata K, Nishikawa H, Abe H, Watanabe K, Kimura T. PMID: 38643665 [PubMed - as supplied by publisher]
	AAT resistance-related AC007405.2 and AL354989.1 as novel diagnostic and prognostic markers in prostate cancer. Aging (Albany NY) Deng Y, Zhang C, Yu H, Chen G, Peng X, Li Y, Feng Z, Shi W, Bai X, Gou X, Liu N. PMID: 38643469 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 169519

Seite 1 von 8476



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung